[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ㉘ | Interview with Dr. Kyungtae Bae, KOL for P198 ExoHealer & ExoNature
Primoris International continued its active global expansion at IMCAS World Congress 2026 in Paris, led by its P198 exosome skin booster line. We spoke with Dr. Kyungtae Bae (Itsme Clinic, Sejong), who served as a speaker at the company's open lecture at the booth to share his clinical experience. P198 comprises two products: ExoHealer, based on umbilical cord blood stem cell-derived exosomes, and ExoNature, based on Panax ginseng-derived plant exosomes. Dr. Bae noted that he had been "looking for safe exosomes from a reliable source," and shared his clinical experience in treating inflammatory skin conditions, melasma, and acne — noting a rapid clinical response and meaningful improvement in skin barrier recovery. He also observed that "international trust in Korean exosome products is growing, and we are in a process of advancing together with physicians abroad," underscoring the rising stature of K-Medical Aesthetics on the global stage.
#MedicalAestheticNews #IMCAS2026 #PrimorisInternational #P198ExoHealer #P198ExoNature #Exosome #DrKyungtaeBae #ItsmeClinic
★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11289

Comments
Post a Comment